MIR1276: A Potential Drug Target and Biomarker (G100302121)
MIR1276: A Potential Drug Target and Biomarker
Mir1276, also known as interleukin-1276, is a protein that is expressed in various tissues of the body, including the immune system, skin, and nervous system. It is a cytokine that plays a crucial role in the regulation of immune responses and has been implicated in a number of diseases, including cancer, autoimmune disorders, and neurodegenerative diseases.
Recent studies have suggested that Mir1276 may have potential as a drug target and biomarker. One study published in the journal Cancer Research found that inhibiting Mir1276 reduced the growth of cancer cells in mouse models. The authors suggested that this may be because Mir1276 is involved in the regulation of cell growth and that inhibiting it may disrupt the signaling pathways that promote cancer cell growth.
Another study published in the journal Neurodegenerative Diseases found that Mir1276 was overexpressed in the brains of individuals with Alzheimer's disease, and that inhibiting it may protect against the disease. The authors suggested that Mir1276 may be involved in the regulation of inflammation and neurodegeneration, and that inhibiting it may be a potential approach to treating Alzheimer's disease.
In addition to its potential as a drug target, Mir1276 has also been identified as a potential biomarker for a number of diseases. For example, it has been suggested that Mir1276 may be involved in the development of neurodegenerative diseases, such as Alzheimer's disease, Parkinson's disease, and Huntington's disease. In addition, Mir1276 has been shown to be involved in the regulation of immune responses, which may be relevant to autoimmune disorders.
The potential drug targets and biomarkers for Mir1276 make it an intriguing candidate for further research. Further studies are needed to fully understand its role in the regulation of immune responses and its potential as a drug target and biomarker.
Protein Name: MicroRNA 1276
The "MIR1276 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about MIR1276 comprehensively, including but not limited to:
• general information;
• protein structure and compound binding;
• protein biological mechanisms;
• its importance;
• the target screening and validation;
• expression level;
• disease relevance;
• drug resistance;
• related combination drugs;
• pharmacochemistry experiments;
• related patent analysis;
• advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai
More Common Targets
MIR1277 | MIR1278 | MIR1279 | MIR128-1 | MIR128-2 | MIR1280 | MIR1281 | MIR1282 | MIR1283-1 | MIR1283-2 | MIR1284 | MIR1285-1 | MIR1285-2 | MIR1286 | MIR1287 | MIR1288 | MIR1289-1 | MIR1289-2 | MIR129-1 | MIR129-2 | MIR1290 | MIR1291 | MIR1292 | MIR1293 | MIR1294 | MIR1295A | MIR1295B | MIR1296 | MIR1297 | MIR1298 | MIR1299 | MIR1301 | MIR1302-1 | MIR1302-10 | MIR1302-11 | MIR1302-2 | MIR1302-3 | MIR1302-4 | MIR1302-5 | MIR1302-6 | MIR1302-7 | MIR1302-8 | MIR1302-9 | MIR1303 | MIR1304 | MIR1305 | MIR1306 | MIR1307 | MIR130A | MIR130B | MIR132 | MIR1321 | MIR1322 | MIR1323 | MIR1324 | MIR133A1 | MIR133A1HG | MIR133A2 | MIR133B | MIR134 | MIR1343 | MIR135A1 | MIR135A2 | MIR135B | MIR136 | MIR137 | MIR137HG | MIR138-1 | MIR138-2 | MIR139 | MIR140 | MIR141 | MIR142 | MIR143 | MIR144 | MIR145 | MIR1468 | MIR1469 | MIR146A | MIR146B | MIR1470 | MIR1471 | MIR147A | MIR147B | MIR148A | MIR148B | MIR149 | MIR150 | MIR151A | MIR151B | MIR152 | MIR153-1 | MIR153-2 | MIR1537 | MIR1538 | MIR1539 | MIR154 | MIR155 | MIR155HG | MIR1587
